Ignite Creation Date:
2024-05-06 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05060627
Status:
RECRUITING
Last Update Posted:
2022-09-08
First Post:
2021-09-17
Brief Title:
Study of Belantamab Mafodotin in Combination With Kd for the Treatment of Relapsed Myeloma Patients Refractory to Lenalidomide
Sponsor:
Organization:
PETHEMA Foundation